Company news
Bausch Health Companies Inc. (TSX:BHC) news
Every Bausch Health Companies Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
August 17, 2026
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
August 6, 2026
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
July 29, 2026
(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic ...
July 28, 2026
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
July 7, 2026
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimburseme...
July 6, 2026
Michael Goettler Resigns from Bausch Health's Board of Directors
July 1, 2026
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI&...
June 9, 2026
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
May 28, 2026
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
May 19, 2026
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
May 13, 2026
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
May 12, 2026
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
April 29, 2026
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through C...
April 14, 2026
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Thro...
April 14, 2026
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
March 31, 2026
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program
March 26, 2026
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 23, 2026
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 23, 2026
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
February 19, 2026
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
February 19, 2026
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
February 18, 2026
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program
February 11, 2026
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
January 23, 2026
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
January 21, 2026
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
December 29, 2025
Bausch Health Announces Final Results and Expiration of Exchange Offers
December 23, 2025
Beauty Devices Markets, Competition and Regional Analysis (2025-2032) Featuring Alma Lasers, Bausch Health, BRAUN, Conair, Cutera, FOREO ...
December 23, 2025
Bausch Health Announces Early Exchange Offer Results for Exchange Offers
December 8, 2025
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
December 1, 2025
Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes
November 24, 2025
Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference
November 18, 2025
Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease
November 5, 2025
Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmace...
October 31, 2025
Bausch Health Announces Third Quarter 2025 Results
October 29, 2025
Bausch Health Announces Results of Special Meeting of Shareholders
October 9, 2025
George Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab Farmacêutica licensing agreement in Brazil
October 2, 2025
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
September 30, 2025
Bausch Health to Announce Third Quarter 2025 Results on October 29
September 30, 2025
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
September 29, 2025
TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors
September 24, 2025
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
September 11, 2025
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, ST...
September 9, 2025
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgi...
September 5, 2025
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
August 26, 2025
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now ...
August 21, 2025
Bausch + Lomb Announces Board Changes
August 18, 2025
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
August 15, 2025
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health
August 12, 2025